104 related articles for article (PubMed ID: 38962175)
1. A comprehensive multi-omics analysis reveals unique signatures to predict Alzheimer's disease.
Vacher M; Canovas R; Laws SM; Doecke JD
Front Bioinform; 2024; 4():1390607. PubMed ID: 38962175
[TBL] [Abstract][Full Text] [Related]
2. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
Clark C; Dayon L; Masoodi M; Bowman GL; Popp J
Alzheimers Res Ther; 2021 Apr; 13(1):71. PubMed ID: 33794997
[TBL] [Abstract][Full Text] [Related]
3. Hyper-graph based sparse canonical correlation analysis for the diagnosis of Alzheimer's disease from multi-dimensional genomic data.
Shao W; Xiang S; Zhang Z; Huang K; Zhang J
Methods; 2021 May; 189():86-94. PubMed ID: 32360353
[TBL] [Abstract][Full Text] [Related]
4. Integrative multi-omics analysis reveals the critical role of the PBXIP1 gene in Alzheimer's disease.
Zhang J; Sun X; Jia X; Sun B; Xu S; Zhang W; Liu Z
Aging Cell; 2024 Feb; 23(2):e14044. PubMed ID: 37984333
[TBL] [Abstract][Full Text] [Related]
5. Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective.
O'Connor LM; O'Connor BA; Lim SB; Zeng J; Lo CH
J Pharm Anal; 2023 Aug; 13(8):836-850. PubMed ID: 37719197
[TBL] [Abstract][Full Text] [Related]
6. JDSNMF: Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.
Moon S; Lee H
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442330
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
8. The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.
Clark C; Rabl M; Dayon L; Popp J
Front Aging Neurosci; 2022; 14():1065904. PubMed ID: 36570537
[TBL] [Abstract][Full Text] [Related]
9. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
Johnstone D; Milward EA; Berretta R; Moscato P;
PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
[TBL] [Abstract][Full Text] [Related]
10. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
[TBL] [Abstract][Full Text] [Related]
11. Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Ponzi E; Thoresen M; Haugdahl Nøst T; Møllersen K
BMC Bioinformatics; 2021 Aug; 22(1):395. PubMed ID: 34353282
[TBL] [Abstract][Full Text] [Related]
12. Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.
Bonnell J; Alcazar O; Watts B; Buchwald P; Abdulreda MH; Ogihara M
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540105
[TBL] [Abstract][Full Text] [Related]
13. Statistical integration of two omics datasets using GO2PLS.
Gu Z; El Bouhaddani S; Pei J; Houwing-Duistermaat J; Uh HW
BMC Bioinformatics; 2021 Mar; 22(1):131. PubMed ID: 33736604
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
[TBL] [Abstract][Full Text] [Related]
15. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
[TBL] [Abstract][Full Text] [Related]
16. Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer's Disease.
François M; Karpe AV; Liu JW; Beale DJ; Hor M; Hecker J; Faunt J; Maddison J; Johns S; Doecke JD; Rose S; Leifert WR
Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295851
[TBL] [Abstract][Full Text] [Related]
17. Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease.
Xie L; He B; Varathan P; Nho K; Risacher SL; Saykin AJ; Salama P; Yan J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971669
[TBL] [Abstract][Full Text] [Related]
18. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus.
Sarnowski C; Huan T; Ma Y; Joehanes R; Beiser A; DeCarli CS; Heard-Costa NL; Levy D; Lin H; Liu CT; Liu C; Meigs JB; Satizabal CL; Florez JC; Hivert MF; Dupuis J; De Jager PL; Bennett DA; Seshadri S; Morrison AC
Clin Epigenetics; 2023 Oct; 15(1):173. PubMed ID: 37891690
[TBL] [Abstract][Full Text] [Related]
19. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]